BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31859537)

  • 1. Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology.
    Haddox CL; Riedel RF
    Expert Rev Anticancer Ther; 2020 Jan; 20(1):5-8. PubMed ID: 31859537
    [No Abstract]   [Full Text] [Related]  

  • 2. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced soft-tissue sarcomas in adults.
    Pinedo HM; Kenis Y
    Cancer Treat Rev; 1977 Jun; 4(2):67-86. PubMed ID: 329988
    [No Abstract]   [Full Text] [Related]  

  • 4. Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
    Noujaim J; Thway K; Sheri A; Keller C; Jones RL
    Int J Surg Pathol; 2016 Feb; 24(1):5-15. PubMed ID: 26399578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histology-driven chemotherapy of soft-tissue sarcoma.
    Eriksson M
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii270-6. PubMed ID: 20943627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
    Penel N; Lebellec L; Blay JY; Robin YM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas.
    Grünhagen DJ; Brunstein F; ten Hagen TL; van Geel AN; de Wilt JH; Eggermont AM
    Cancer Treat Res; 2004; 120():65-79. PubMed ID: 15217218
    [No Abstract]   [Full Text] [Related]  

  • 8. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue sarcoma in childhood and adolescence.
    Raney RB
    Curr Oncol Rep; 2002 Jul; 4(4):291-8. PubMed ID: 12044238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
    Aragon-Ching JB; Maki RG
    Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for metastatic soft tissue sarcomas--another full circle?
    Bramwell VH
    Br J Cancer; 1991 Jul; 64(1):7-9. PubMed ID: 1854630
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs.
    Wagner A
    J Natl Compr Canc Netw; 2007 Apr; 5(4):401-10. PubMed ID: 17442231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
    Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
    Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.
    Alavi SN; Florou V; Tinoco G; Trent JC; Wilky BA
    Discov Med; 2018 Mar; 25(137):131-144. PubMed ID: 29641974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas.
    Ray A; Huh WW
    Curr Oncol Rep; 2012 Aug; 14(4):311-9. PubMed ID: 22535507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.
    Reed D; Altiok S
    Cancer Control; 2011 Jul; 18(3):188-95. PubMed ID: 21666581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
    Blay JY; Cassier PA; Ray-Coquard I
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trails referral resource. Clinical trials in soft tissue sarcomas.
    Saxman S; Schoenfeldt M
    Oncology (Williston Park); 2002 Oct; 16(10):1359-60. PubMed ID: 12435205
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathological anatomy of sarcomas of the bone and soft tissue].
    Contesso G; Coindre JM; Mazabraud A
    Bull Cancer; 1988; 75(5):431-43. PubMed ID: 3395707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.